Wednesday, 21 Feb 2018

You are here

ACR/AAHKS Guidelines on Perioperative Management

The American College of Rheumatology has partnered with the American Association of Hip and Knee Surgeons to develop consensus-based guidelines for perioperative management of antirheumatic therapies for patients with rheumatic diseases who plan to undergo total joint replacement.

A multidisciplinary panel of orthopedists, rheumatologists and patients reviewed the available evidence regarding the safety of steroid, DMARD or biologic perioperatively, with the primary goal being the reduction in infectious risk and perioperative infections. The recommendations are primarily expert opinion with some guidance from prior studies.

The ACR published these new ACR/AAHKS guidelines on its website (Citation source: http://buff.ly/2rSoja8 ).

These are intened to aid the managment of patients with inflammatory rheumatic diseasea undergoing total knee arthroplasty (TKA) or total hip arthroplasty (THA).

The guidelines discuss perioperative management of patients with rheumatoid arthritis (RA), spondyloarthritis (SpA), juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE).

These guidelines specifically address the use of corticosteroids, DMARDs, biologic agents, and tofacitinib.

7 Primary Recommendations Governing Anti-Rheumatic Drug Use in Rheumatic disease Patients Undergoing Elective THA or TKA:

  1. Nonbiologic-DMARDs should be continued in the during and throughout the perioperative period for patients TKA or THA.
  2. Biologic therapies should be withheld for surgery and prior to surgery, biologics should be held for one-dosing cycle or surgery should be planned for the end of the dosing cycle. of that medication.
  3. Tofacitinib be withheld 7 days before surgery in patients with RA, SpA and JIA.
  4. Severe SLE patients: continue methotrexate, mycophenolate mofetil, azathioprine, cyclosporine or tacrolimus in cases with severe SLE through the surgical period.
  5. However, non-severe SLE: mycophenolate mofetil, azathioprine, cyclosporine or tacrolimus should be withheld 1 week before patients undergo total joint replacement.
  6. Biologic therapy that was withheld prior to surgery should be re-started with evidence of wound healing and no sign of infection or drainage (~14 days).
  7. There is no need/utility to "stress dose steroids" for those on chronic steroids; the panel recommended the continued use of daily dose of glucocorticoids for patients throughout surgery.

The evidence for each of these was low as there are few if any well designed trials to answer these questions conclusively.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Calcium and Vitamin D Do Not Increase Cardiac Events/Death

An analysis of the UK Biobank study found no link between calcium/vitamin D supplementation and incident cardiovascular events/deaths in a large prospective study of 475,255 men and women aged 40 to 69 years.

Results published in Journal of Bone and Mineral Research used registry data to identify coded incident hospital admissions for ischemic heart disease (IHD), myocardial infarction (MI), and subsequent death.

Apremilast Continues to Look Good in Behcet's Disease

The 2018 American Academy of Dermatology Annual Meeting features recent findings of a phase III trial of apremilast in active Behçet’s Disease, showing significant reductions in oral ulcers at week 12 for those treated with apremilast 30 mg twice daily.

Methotrexate May Help in Chronic Chikungunya Arthritis

Methotrexate may provide benefits in treatment of the chronic arthritis that can persist following acute chikungunya virus infection, but definitive evidence remains lacking, researchers reported.

15% of Users Exceed Recommended OTC NSAID Dosing

New data shows that nearly 15 percent of adult ibuprofen users exceed the maximum recommended dose of ibuprofen or other NSAIDs in a one-week period. 

An online study analyzed NSAID use with a 1-week diary study that included 1326 ibuprofen users. The vast majority (90%) of ibuprofen use was from over-the-counter use.

Laparoscopic Gastric Sleeve Compared to Bypass Bariatric Surgery

JAMA reports the results of a 5 year Finnish study comparing the results of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass and shows that gastric bypass yielded greater weight loss at 5 years, the difference was not statistically significant, in patients with morbid obesity.